Contraindications for the use of Effortil®
Patients suffering from the following diseases must not take Effortil®:
- Hyperthyroidism
- Pheochromocytoma: here, an uncontrolled release of adrenalin and noradrenalin occurs in the adrenal gland.
- Glaucoma (increased intraocular pressure)
- Bladder voiding disorders, including prostate enlargement
- High blood pressure
- Cardiac arrhythmia associated with an increased heart rate (e.g. atrial fibrillation)
- Coronary heart disease (due to narrowing of the coronary arteries)
- Narrowed heart valves (e.g.
Interactions
When certain medications are taken simultaneously with Effortil®, life-threatening interactions occur:
- Extreme increase in blood pressure: among others, certain asthma drugs (e.g. fenoterol or antihistamines), thyroid hormones
- Tachycardia, cardiac arrhythmia: Atropine, digitalis preparations
- Reduced blood pressure lowering effect when taking antidiabetics (e.g. metformin)
Use during pregnancy
Effortil® should never be taken during the first trimester of pregnancy. The same applies to the breastfeeding period. that the drug passes into breast milk: it should therefore not be taken when breastfeeding.
In late pregnancy, a consultation with the supervising gynecologist should be made before taking the drug. Low blood pressure during pregnancy Because of its performance-enhancing effect (stimulant), Effortil® is considered a doping agent and is therefore prohibited in competitive sports.
